Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-16-032004
Filing Date
2016-05-16
Accepted
2016-05-16 15:06:00
Documents
48
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q blgo20160330_10q.htm 10-Q 723983
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 10387
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 10414
4 EXHIBIT 32 ex32.htm EX-32 9624
  Complete submission text file 0001437749-16-032004.txt   3560527

Data Files

Seq Description Document Type Size
5 EXHIBIT 101.INS blgo-20160331.xml EX-101.INS 637569
6 EXHIBIT 101.SCH blgo-20160331.xsd EX-101.SCH 37742
7 EXHIBIT 101.CAL blgo-20160331_cal.xml EX-101.CAL 24002
8 EXHIBIT 101.DEF blgo-20160331_def.xml EX-101.DEF 290132
9 EXHIBIT 101.LAB blgo-20160331_lab.xml EX-101.LAB 232743
10 EXHIBIT 101.PRE blgo-20160331_pre.xml EX-101.PRE 304323
Mailing Address 3500 W. GARRY AVENUE SANTA ANA CA 92704
Business Address 3500 W. GARRY AVENUE SANTA ANA CA 92704 949-643-9540
BIOLARGO, INC. (Filer) CIK: 0000880242 (see all company filings)

EIN.: 650159115 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19709 | Film No.: 161653035
SIC: 2800 Chemicals & Allied Products